Advertisement
News
Advertisement

RXi teams up with EyeGate Pharma

Wed, 09/22/2010 - 9:32am
Mass High Tech: The Journal of New England Technology

RXi Pharmaceuticals Corp. of Worcester and EyeGate Pharmaceuticals Inc. of Waltham today said they will collaborate on an effort to deliver RNAi therapeutics to the eye to treat retinal disorders.

According to RXi president and CEO Noah Beerman, pre-clinical studies of RXi’s sd-rxRNA compounds have shown effective gene silencing in the retina after intraocular injection.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading